提示: 手机请竖屏浏览!

乳腺癌筛查
Breast-Cancer Screening


Ellen Warner ... 肿瘤 • 2011.09.15
相关阅读
• 帮助75岁及以上女性制订乳腺X线筛查决策 • ACP新发布的指南声明:一般风险女性的乳腺癌筛查 • 补充性乳腺磁共振成像检查和乳房X线筛查的风险及益处比较 • 美国妇产科医师学会更新遗传性乳腺癌卵巢癌综合征诊疗指南 • 临床乳腺检查在筛查性乳房X线摄影尚未普及时的价值

杂志的这一部分首先引入一个病例摘要来强调一个常见的临床问题,然后提出有证据支持的各种策略。如果存在正式的指南,作者则对此进行综述。文章以作者的临床建议结尾。

 

一位健康的42岁白人女性想要讨论是否进行乳腺癌筛查。她没有乳房不适症状,14岁月经初潮,26岁生了第一个孩子,属于中度超重,经常晚上喝2杯葡萄酒,没有乳腺癌或卵巢癌的家族史。她从来没有接受过乳腺钼靶检查,提到自己的一个一直保持“最健康生活方式”的朋友现在正在接受转移性乳腺癌的治疗。她希望避免同样的命运。你会给予什么建议?





作者信息

Ellen Warner, M.D.
From the Division of Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto. Address reprint requests to Dr. Warner at the Division of Medical Oncology, Sunnybrook Health Sciences Centre, 2075 Bayview Ave., Toronto, ON M4N 3M5, Canada, or at ellen.warner@sunnybrook.ca.

 

参考文献

1. American Cancer Society. Global cancer facts and figures 2008. (http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-027766.pdf.)

2. SEER stat fact sheets: breast. (http://seer.cancer.gov/statfacts/html/breast.html.)

3. Tice JA, Kerlikowske K. Screening and prevention of breast cancer in primary care. Prim Care 2009;36:533-558

4. Baum M, Ravdin PM. Decision-making in early breast cancer: guidelines and decision tools. Eur J Cancer 2002;38:745-749

5. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767-772

6. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-1792

7. Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137:344-346

8. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med2009;151:727-737

9. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89[Erratum, CA Cancer J Clin 2007;57:185.]

10. Habbema JD, van Oortmarssen GJ, van Putten DJ, Lubbe JT, van der Maas PJ. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst 1986;77:317-320

11. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up: a randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137:305-312

12. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials.Lancet 2002;359:909-919[Erratum, Lancet 2002;360:724.]

13. Bjurstam N, Bjorneld L, Warwick J, et al. The Gothenburg Breast Screening Trial. Cancer2003;97:2387-2396

14. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006;368:2053-2060

15. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-1499

16. Alexander FE, Anderson TJ, Brown HK, et al. 14 Years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999;353:1903-1908

17. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:347-360

18. Jonsson H, Bordas P, Wallin H, Nystrom L, Lenner P. Service screening with mammography in northern Sweden: effects on breast cancer mortality -- an update. J Med Screen 2007;14:87-93

19. Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009;151:738-747[Erratum, Ann Intern Med 2010;152:136.]

20. Hendrick RE, Smith RA, Rutledge JH III, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;22:87-92

21. Kerlikowske K, Grady D, Ernster V. Benefit of mammography screening in women ages 40-49 years: current evidence from randomized controlled trials. Cancer 1995;76:1679-1681

22. Berg WA. Benefits of screening mammography. JAMA 2010;303:168-169

23. Hendrick RE, Helvie MA. United States Preventive Services Task Force screening mammography recommendations: science ignored. AJR Am J Roentgenol 2011;196:W112-W116

24. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-154

25. Wai ES, D'yachkova Y, Olivotto IA, et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer 2005;92:961-966

26. Goel A, Littenberg B, Burack RC. The association between the pre-diagnosis mammography, screening interval and advanced breast cancer. Breast Cancer Res Treat2007;102:339-345

27. White E, Miglioretti DL, Yankaskas BC, et al. Biennial vs. annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst 2004;96:1832-1839

28. Bailey SL, Sigal BM, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. J Natl Cancer Inst 2010;102:1263-1271

29. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005;353:1773-1783[Erratum, N Engl J Med 2006;355:1840.]

30. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med1998;338:1089-1096

31. Christiansen CL, Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst 2000;92:1657-1666

32. Barton MB, Morley DS, Moore S, et al. Decreasing women's anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst 2004;96:529-538

33. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502-510

34. Drossaert CH, Boer H, Seydel ER. Does mammographic screening and a negative result affect attitudes towards future breast screening? J Med Screen 2001;8:204-212

35. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230-234

36. Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30[Erratum, J Med Screen 2010;17:106.]

37. Welch HG, Black WC. Overdiagnosis of cancer. J Natl Cancer Inst 2010;102:605-613

38. Yaffe MJ, Mainprize JG. Risk of radiation-induced breast cancer from mammographic screening. Radiology 2011;258:98-105

39. Tice JA, Feldman MD. Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog?Breast Cancer Res Treat 2008;107:157-165

40. Welch HG, Woloshin S, Schwartz LM. The sea of uncertainty surrounding ductal carcinoma in situ -- the price of screening mammography. J Natl Cancer Inst 2008;100:228-229

41. Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst2006;98:774-782

42. Ahern CH, Shen Y. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines. Cancer Epidemiol Biomarkers Prev 2009;18:718-725

43. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians.Ann Intern Med 2007;146:516-526

44. Amir E, Freedmen OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-691

45. National Cancer Institute. Breast cancer risk assessment tool. (http://www.cancer.gov/bcrisktool/Default.aspx.)

46. Decarli A, Calza S, Masala G, Specchia C, Palli D, Gail MH. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst2006;98:1686-1693

47. IBIS breast cancer risk evaluation tool. (http://www.ems-trials.org/riskevaluator.)

48. Lund MJ, Trivers KF, Porter PL, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 2009;113:357-370

49. del Carmen MG, Halpern EF, Kopans DB, et al. Mammographic breast density and race.AJR Am J Roentgenol 2007;188:1147-1150

50. Pisani P, Parkin DM, Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006;118:149-154

51. Boulos S, Gadallah M, Neguib S, et al. Breast screening in the emerging world: high prevalence of breast cancer in Cairo. Breast 2005;14:350-356

52. National Cancer Institute. Cancer control research: early detection of common cancers in women in India. (http://cancercontrol.cancer.gov/grants/abstract.asp?applid=6965060.)

53. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection. Cochrane Database Syst Rev 2003;2:CD003373-CD003373

54. Corsetti V, Houssami N, Ferrari A, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer 2008;44:539-544

55. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs. mammography alone in women at elevated risk of breast cancer. JAMA2008;299:2151-2163

56. Helvie MA. Digital mammography imaging: breast tomosynthesis and advanced applications. Radiol Clin North Am 2010;48:917-929

服务条款 | 隐私政策 | 联系我们